Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Co Codamol Codeine And Paracetamol

Co Codamol Codeine And Paracetamol

Co-Codamol: Therapeutic Use, Pharmacology, Risks, and Regulation of a Widely Used Analgesic

Introduction

Pain is a universal experience, and effective pain relief is a cornerstone of modern medicine. Co-Codamol, a combination analgesic composed of codeine phosphate and paracetamol (acetaminophen), is commonly prescribed for the management of moderate pain that is not relieved by paracetamol or non-steroidal anti-inflammatory drugs (NSAIDs) alone.

1. Co-Codamol

Co-Codamol is a fixed-dose combination of:

  • Codeine phosphate: A mild opioid analgesic.

  • Paracetamol (acetaminophen): A non-opioid analgesic and antipyretic.

It is used primarily for moderate pain, especially when single-agent paracetamol is ineffective.

Available Strengths (UK Formulation Examples)

Strength Codeine (mg) Paracetamol (mg) Availability
Low 8 500 OTC (pharmacy only)
Medium 15 500 Prescription only
High 30 500 Prescription only

2. Mechanism of Action

Codeine

Codeine is a prodrug that is metabolized in the liver by the CYP2D6 enzyme into morphine, which then acts on mu-opioid receptors in the brain and spinal cord to:

  • Reduce the perception of pain

  • Increase pain tolerance

  • Induce a sense of euphoria (which contributes to its abuse potential)

Paracetamol

The exact mechanism is not fully understood, but paracetamol likely works by:

  • Inhibiting prostaglandin synthesis in the CNS

  • Modulating serotonergic pathways involved in pain processing

It is not anti-inflammatory but has potent analgesic and antipyretic effects.

3. Indications

Co-Codamol is indicated for:

  • Moderate pain unrelieved by paracetamol, ibuprofen, or aspirin

  • Postoperative pain

  • Dental pain

  • Musculoskeletal pain (e.g., back pain, sprains)

  • Migraine (when NSAIDs are contraindicated)

It is not first-line for chronic pain due to risks of dependence.

4. Dosage and Administration

Adults and Children Over 12

  • Low-strength Co-Codamol (8/500): 1–2 tablets every 4–6 hours as needed; max 8 tablets/day.

  • High-strength (30/500): Up to 1–2 tablets every 4–6 hours; max 8 tablets/day.

  • Do not exceed 4 grams of paracetamol per day.

Children under 12

  • Not recommended due to risk of respiratory depression and variable metabolism of codeine.

Elderly

  • Use with caution. Start with lower doses due to increased sensitivity to opioids and higher risk of side effects.

5. Pharmacokinetics

Codeine

  • Absorption: Well absorbed orally.

  • Metabolism: Liver metabolism via CYP2D6 into morphine.

  • Half-life: ~3 hours.

  • Excretion: Renal.

Paracetamol

  • Absorption: Rapid and complete oral absorption.

  • Metabolism: Liver metabolism via glucuronidation and sulfation.

  • Half-life: 2–3 hours.

  • Excretion: Renal.

6. Efficacy in Pain Management

Co-Codamol is more effective than paracetamol alone for:

  • Postoperative dental pain

  • Soft tissue injuries

  • Migraine (limited role)

  • Musculoskeletal pain

However, evidence supports limited duration of use (3–5 days) for acute pain, with risk-benefit concerns in prolonged use.

7. Side Effects

Common Side Effects

  • Constipation

  • Nausea and vomiting

  • Drowsiness

  • Dizziness

  • Dry mouth

Serious Side Effects

  • Respiratory depression (especially in CYP2D6 ultra-rapid metabolizers)

  • Liver damage (due to paracetamol overdose)

  • Hypotension

  • Allergic reactions (e.g., skin rash, anaphylaxis)

  • Dependence and addiction (due to codeine)

8. Codeine: Metabolism and Risks

Codeine's effectiveness and safety are highly dependent on individual CYP2D6 metabolism. There are:

  • Poor metabolizers: Inadequate pain relief

  • Ultra-rapid metabolizers: Increased conversion to morphine → risk of toxicity (respiratory depression)

Genetic Variability

  • Up to 10% of Caucasians are poor metabolizers.

  • Up to 30% of North Africans and Ethiopians are ultra-rapid metabolizers.

Because of this, routine use of codeine in children and breastfeeding women is contraindicated.

9. Paracetamol Toxicity

Paracetamol overdose is a leading cause of acute liver failure.

Toxic Dose

  • Adults: >4 g/day (therapeutic max)

  • Acute toxicity: ~10 g or more in a single dose

Signs of Toxicity

  • Nausea and vomiting

  • Right upper quadrant pain

  • Elevated liver enzymes

  • Hepatic failure within 48–72 hours

Management

  • Activated charcoal (within 1 hour)

  • N-acetylcysteine (NAC): Antidote to prevent liver damage

10. Addiction and Misuse

Codeine can lead to opioid use disorder with:

  • Tolerance (need for increasing dose)

  • Dependence (withdrawal symptoms)

  • Misuse (crushing tablets for snorting or injecting)

  • Psychological cravings

Warning Signs

  • Using more than prescribed

  • Requesting early refills

  • Doctor shopping

  • Continued use despite harm

Because of this, Co-Codamol is regulated differently across jurisdictions.

11. Regulatory Status

United Kingdom

  • Low-dose Co-Codamol (8/500): Pharmacy medicine (P); available OTC with restrictions.

  • Higher doses (15/500 and 30/500): Prescription-only medicine (POM).

United States

  • Combination codeine products (including with acetaminophen) are Schedule III or IV controlled substances, depending on codeine content.

Australia

  • All codeine-containing products are prescription-only since 2018.

12. Dependence, Withdrawal, and Tapering

Withdrawal Symptoms

  • Restlessness, anxiety

  • Sweating

  • Insomnia

  • Abdominal cramps

  • Nausea

  • Diarrhea

Tapering under medical supervision is advised for individuals using Co-Codamol regularly for more than a few weeks.

13. Safer Use Recommendations

  • Use lowest effective dose for shortest duration.

  • Avoid other paracetamol-containing medications to reduce overdose risk.

  • Avoid alcohol (increased risk of liver toxicity and sedation).

  • Monitor for signs of dependence and withdrawal.

  • Educate patients on maximum daily dose and safe storage.

14. Alternative Therapies

Depending on the clinical scenario, alternatives include:

Pain Type Alternative Options
Mild to moderate Paracetamol, ibuprofen
Inflammatory pain NSAIDs (e.g., naproxen, diclofenac)
Severe acute pain Tramadol, morphine (short-term, supervised)
Neuropathic pain Gabapentin, pregabalin, amitriptyline
Chronic pain Multimodal approach, non-pharmacologic therapy

15. Public Health Considerations

Overuse and Poisonings

  • Paracetamol overdose is a leading cause of acute liver failure worldwide.

  • Codeine dependence is increasingly recognized, especially among young adults.

Educational Campaigns

  • Encourage rational prescribing and patient education.

  • Limit repeat prescriptions without review.

  • Implement real-time prescription monitoring (e.g., Australia’s SafeScript).

16. Conclusion

Co-Codamol is a useful and effective analgesic for short-term relief of moderate pain, but it is not without risks. The combination of codeine, a metabolically variable opioid, and paracetamol, a hepatotoxic compound in overdose, demands careful patient selection, monitoring, and counseling. While it remains widely used and accessible, its role in pain management is increasingly scrutinized, especially in light of the global opioid epidemic and frequent paracetamol-related toxicities. Clinicians must weigh the benefits against the risks and consider alternative treatments where appropriate.

Key Takeaways

  • Co-Codamol is a combination of codeine and paracetamol used for moderate pain.

  • It should be used for the shortest duration at the lowest effective dose.

  • Risk of addiction, liver damage, and respiratory depression requires careful use.

  • Patient education and regulatory controls are essential to safe prescribing.

  • Genetic variability in codeine metabolism can dramatically influence outcomes.

Avaiable Medicines